Single User License
INR 101895
Site License
INR 203790
Corporate User License
INR 305685

Service Tax Additional

select a format
Price

Single User License
USD 1500
Site License
USD 3000
Corporate User License
USD 4500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


AlgiPharma AS-Product Pipeline Review-2015

AlgiPharma AS-Product Pipeline Review-2015


  Request for Sample Report

Executive Summary

AlgiPharma AS-Product Pipeline Review-2015

Summary

Global Markets Direct's, 'AlgiPharma AS-Product Pipeline Review-2015', provides an overview of the AlgiPharma AS's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of AlgiPharma AS's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides brief overview of AlgiPharma AS including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of AlgiPharma AS's human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the AlgiPharma AS's pipeline products

Reasons To Buy

Evaluate AlgiPharma AS's strategic position with total access to detailed information on its product pipeline

Assess the growth potential of AlgiPharma AS in its therapy areas of focus

Identify new drug targets and therapeutic classes in the AlgiPharma AS's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of AlgiPharma AS and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of AlgiPharma AS

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of AlgiPharma AS and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

AlgiPharma AS Snapshot 4

AlgiPharma AS Overview 4

Key Information 4

Key Facts 4

AlgiPharma AS-Research and Development Overview 5

Key Therapeutic Areas 5

AlgiPharma AS-Pipeline Review 7

Pipeline Products by Stage of Development 7

Pipeline Products-Monotherapy 8

AlgiPharma AS-Pipeline Products Glance 9

AlgiPharma AS-Clinical Stage Pipeline Products 9

Phase II Products/Combination Treatment Modalities 9

Phase I Products/Combination Treatment Modalities 10

AlgiPharma AS-Early Stage Pipeline Products 11

Preclinical Products/Combination Treatment Modalities 11

AlgiPharma AS-Unknown Stage Pipeline Products 12

Unknown Products/Combination Treatment Modalities 12

AlgiPharma AS-Drug Profiles 13

Oligomer G for Cystic Fibrosis 13

Product Description 13

Mechanism of Action 13

R&D Progress 13

Oligomer G for COPD 15

Product Description 15

Mechanism of Action 15

R&D Progress 15

Oligomer G for Wounds and Burns 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

Oligomer G for Pseudomonas Aeruginosa Infectious 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

AlgiPharma AS-Pipeline Analysis 18

AlgiPharma AS-Pipeline Products by Route of Administration 18

AlgiPharma AS-Pipeline Products by Molecule Type 19

AlgiPharma AS-Recent Pipeline Updates 20

AlgiPharma AS-Locations And Subsidiaries 21

Head Office 21

Appendix 22

Methodology 22

Coverage 22

Secondary Research 22

Primary Research 22

Expert Panel Validation 22

Contact Us 22

Disclaimer 23

List of Tables

AlgiPharma AS, Key Information 4

AlgiPharma AS, Key Facts 4

AlgiPharma AS-Pipeline by Indication, 2015 6

AlgiPharma AS-Pipeline by Stage of Development, 2015 7

AlgiPharma AS-Monotherapy Products in Pipeline, 2015 8

AlgiPharma AS-Phase II, 2015 9

AlgiPharma AS-Phase I, 2015 10

AlgiPharma AS-Preclinical, 2015 11

AlgiPharma AS-Unknown, 2015 12

AlgiPharma AS-Pipeline by Route of Administration, 2015 18

AlgiPharma AS-Pipeline by Molecule Type, 2015 19

AlgiPharma AS-Recent Pipeline Updates, 2015 20

List of Figures

AlgiPharma AS-Pipeline by Top 10 Indication, 2015 6

AlgiPharma AS-Pipeline by Stage of Development, 2015 7

AlgiPharma AS-Monotherapy Products in Pipeline, 2015 8

AlgiPharma AS-Pipeline by Top 10 Molecule Type, 2015 19

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Current R&D Portfolio of AlgiPharma AS; AlgiPharma AS - Key Therapeutics; AlgiPharma AS - Pipeline Overview and Promising Molecules; AlgiPharma AS - News; AlgiPharma AS - Latest Updates; AlgiPharma AS - Pipeline; AlgiPharma AS - Discontinued/Dormant Projects


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com